Page 74

72

References 1. Outterson K (2012) Regulating compounding pharmacies after NECC. New Engl J Med 367(21): 1969-1972. 2. Barchenger S (January 8, 2017) First criminal trial in deadly meningitis outbreak to begin. The Tennessean. available from: http://www.floridatoday.com/story/news/ nation-now/2017/01/09/first-criminal-trial-deadly-fungal-meningitis-outbreak-beginsmonday/96331252/ 3. Majno G (1978) The Healing Hand: Man and wound in the ancient world. Harvard University Press, Cambridge. 4. Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heis EH, et al. (2015) Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv 33(8): 1582-1614.

The Pharmacologist, Volume 59, Number 2, June 2017

5. Pryor TCS (January 29, 2014) The history of the legal and regulatory issues surrounding pharmacy compounding. FDLI presentation. available from: http:// docplayer.net/21295868-The-history-of-the-legal-and-regulatory-issues-surroundingpharmacy-compounding.html 6. Anderson RJ (2011) Lady Mildmay’s modern medical cures. Mol Interv 11(2): 72-78. 7. University Compounding Pharmacy. History of compounding. available from: http:// ucprx.com/compoundinghistory 8. Adams Drugs. The history of compounding. available from: http://www.adamsdrugs. net/pharmacy-services/history-of-compounding.php 9. Crosse M (July 31, 2013) GAO Report to Congressional Requesters. Drug Compounding: Clear authority and more reliable data needed to strengthen FDA oversight (GAO-13-702). available from: http://www.gao.gov/products/GAO-13-702 10. Woodcock J (May 23, 2013) Examining drug compounding: Testimony before Subcommittee on Health, Committee on Energy and Commerce, US House of Representatives. available from: http://www.fda.gov/NewsEvents/Testimony/ ucm353654.htm 11. Kunac T (July 2013) Intravenous Therapy: Then and now. available from: http://www. ivnnz.co.nz/files/file/7748/Intravenous%20Therapy%20%20Then%20and%20Now%20 %20July%202013.pdf 12. Cantrell S A (2016) Improving the quality of compounded sterile drug products: A historical perspective. Ther Innov Regul Sci 50(3): 266-269. 13. CBS/AP (May 20, 2015) Judge approves $200 million settlement over meningitis outbreak. available from: http://www.cbsnews.com/news/judge-approves-200-millionsettlement-over-meningitis-outbreak/ 14. Bidgood J and Tavernise S (December 17, 2014) Pharmacy executives face murder charges in meningitis deaths. New York Times; available from: https://www.nytimes. com/2014/12/18/us/new-england-compounding-center-steroid-meningitis-arrests.html?_ r=0 15. FDA (February 10, 2003) Form 483 Inspectional Observations. FEI Number 3003623877. available from: http://www.fda.gov/downloads/AboutFDA/CentersOffices/ OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/ UCM325834.pdf 16. FDA (December 2, 2013) Historical pharmacy compounding information. available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ PharmacyCompounding/ucm376286.htm 17. Eichenwald K (April 16, 2015) Killer pharmacy: Inside a medical mass murder case. Newsweek. available from: http://www.newsweek.com/2015/04/24/inside-one-mostmurderous-corporate-crimes-us-history-322665.html 18. Pettit AC, Kropski JA, Castilho JL, Schmitz JE, Rouch CA, Mobley BC, Wang XJ, Spires SS, and Pugh ME (2012) The index case for the fungal meningitis outbreak in the United States. New Engl J Med 367(22): 2119-2125.

Reprinted from The Pharmacologist • June 2017

Profile for ASPET

2018 Special Compilation Issue of The Pharmacologist  

ASPET is pleased to present the second in a series of special editions of our quarterly news magazine, The Pharmacologist. This special com...

2018 Special Compilation Issue of The Pharmacologist  

ASPET is pleased to present the second in a series of special editions of our quarterly news magazine, The Pharmacologist. This special com...